Transcriptional activities of estrogen receptor alpha and beta in yeast properties of raloxifene 1 1Abbreviations: ERE, estrogen response element; E2, 17β-estradiol; RAL, raloxifene; ERα, estrogen receptor α; ERβ, estrogen receptor β; and SERM, selective estrogen receptor modulator.
- 30 August 2001
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 62 (7) , 953-961
- https://doi.org/10.1016/s0006-2952(01)00731-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Molecular Pharmacology of SERMsTrends in Endocrinology & Metabolism, 1999
- Targeted Antiestrogens to Prevent Breast CancerTrends in Endocrinology & Metabolism, 1999
- Estrogen receptor and the SERM conceptJournal of Endocrinological Investigation, 1999
- Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- Pharmacokinetics of raloxifene and its clinical applicationEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1999
- Estrogen receptor as a target for the prevention of breast cancerJournal of Laboratory and Clinical Medicine, 1999
- Molecular basis of agonism and antagonism in the oestrogen receptorNature, 1997
- Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and βEndocrinology, 1997
- Mechanisms for tamoxifen resistance in breast cancer: Possible role of tamoxifen metabolismThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Tamoxifen in premenopausal patients with metastatic breast cancer: a review.Journal of Clinical Oncology, 1991